Safety Evaluation for New Drug Approval in Korea

被引:0
|
作者
Young-Ok Kim
Kwang-Won Ha
Kwang-Sik Choi
机构
[1] National Institute of Toxicological Research,General Toxicology Division
[2] Korea Food & Drug Administration,undefined
[3] Toxicology Department,undefined
关键词
Toxicity guidelines; Korea; New drug approval;
D O I
暂无
中图分类号
学科分类号
摘要
Current drug regulation in Korea is based on the Pharmaceutical Affairs Law, which has been revised 14 times. Toxicity guidelines are described in the Regulation for Evaluation on Safety and Efficacy of Drugs (Korea Food and Drug Administration Notification No. 1999–60, revised on December 22, 1999) and Guidelines for Toxicity Studies of Drugs (Korea Food and Drug Administration Notification No. 1999–61, revised on December 22, 1999). This paper describes the review process and toxicity guidelines for new drug approval in Korea.
引用
下载
收藏
页码:285 / 291
页数:6
相关论文
共 50 条
  • [1] Safety evaluation for new drug approval in Korea
    Kim, YO
    Ha, KW
    Choi, KS
    DRUG INFORMATION JOURNAL, 2001, 35 (01): : 285 - 291
  • [2] Immunotoxicity Evaluation and Guidelines for Drug Approval in Korea
    Young-Ok Kim
    Hyejoo Chung
    Kwang-Sup Kil
    Jae-Hyun Park
    Dong-Sup Kim
    Dae-Hyun Cho
    Drug information journal : DIJ / Drug Information Association, 2000, 34 : 25 - 32
  • [3] Immunotoxicity evaluation and guidelines for drug approval in Korea
    Kim, YO
    Chung, H
    Kil, KS
    Park, JH
    Kim, DS
    Cho, DH
    DRUG INFORMATION JOURNAL, 2000, 34 (01): : 25 - 32
  • [4] THE SAFETY AND EFFICACY OF NEW DRUG APPROVAL
    GIERINGER, DH
    CATO JOURNAL, 1985, 5 (01) : 177 - 201
  • [5] Safety concerns slow new drug review and approval processes
    Wechsler, Jill
    FORMULARY, 2009, 44 (11) : 341 - 342
  • [6] Regulations and procedures for new drug evaluation and approval in China
    Yin, Hongzhang
    HUMAN GENE THERAPY, 2006, 17 (10) : 970 - 974
  • [7] NEW DRUG APPROVAL
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2009, 109 (10) : 32 - 32
  • [8] Faster drug approval: challenges for safety
    Preziosi, Paolo
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (09) : 1205 - 1218
  • [9] Speed and Safety in Drug Approval and Commercialization
    Unguru, Yoram
    PEDIATRICS, 2017, 140 (05)
  • [10] Safety approval for new trains - Is it reducing safety?
    Hitachi Rail Group, United Kingdom
    1600, 105-116 (2006):